MVIL, LLC
SEC CIK 1914583 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 10% | 10.42M | $5.00M | — | 2 | 2022-01-11 | 2022-01-11 |
Most active insiders at AMLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Klee Justin B. | Co-CEO, Dir | — | $4.03M |
| 2 | Cohen Joshua B | Co-CEO, Dir | — | $4.03M |
| 3 | Mazzariello Gina | CLO | — | $1.18M |
| 4 | FRATES JAMES M | CFO | — | $708.4K |
| 5 | Bedrosian Camille L | Chief Medical Off | — | $689.0K |
| 6 | Firestone Karen | Dir | $152.2K | — |
| 7 | MILNE GEORGE M JR | Dir | — | — |
MVIL, LLC made no open-market trades at AMLX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DAI | 2022-03-17 | 2022-01-11 | AMLX | Amylyx Pharmaceuticals, Inc. | MVIL, LLC | 10% | C - Cnv Deriv | — | +10.42M | 10.42M | New | — |
| DAI | 2022-03-17 | 2022-01-11 | AMLX | Amylyx Pharmaceuticals, Inc. | MVIL, LLC | 10% | P - Purchase | $19.00 | +263.2K | 10.68M | +3% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations